Why This Matters
Hepatoblastoma resection is one of the bloodier operations in pediatric oncology 0:00. The tumor is vascular, the liver parenchyma friable, and the patient often small. Transfusion during the case is common 0:00. Until recently, the assumption has been that keeping hemoglobin up is the priority — get red cells in, stabilize the patient, finish the operation 0:00. A 2025 multi-institutional study in *Pediatric Blood and Cancer* challenges that reflex 0:13. It suggests that the *composition* of what we transfuse may matter as much as the decision to transfuse at all, and that red cell–predominant strategies may be driving postoperative coagulopathy 0:19.
The Core Problem
The study examined whether intraoperative transfusion affects oncologic outcomes — specifically recurrence and survival 0:19. The findings split cleanly: transfusion had no effect on recurrence but was associated with increased mortality 0:32. That association alone does not prove causation; sicker patients get more blood 0:32. But two other findings point to a modifiable problem 0:39. First, some transfusions appeared unnecessary — patients who received blood intraoperatively had *higher* postoperative hemoglobin levels, suggesting they were not profoundly anemic to begin with 0:43. Second, despite receiving blood during the operation, these same patients required more plasma and platelets afterward 0:43.
That pattern — adequate red cell mass but ongoing need for coagulation support — suggests the transfusion strategy itself may have worsened coagulopathy rather than correcting it 0:52.
What the Transfusion Data Showed
Among patients who were transfused intraoperatively, the majority received red blood cells 0:25. Only a minority received platelets 0:25. This is a red cell–heavy approach, and it reflects standard practice in many centers: hemorrhage prompts a call for packed cells, and unless there is obvious microvascular bleeding or a laboratory coagulopathy, platelets and plasma are held back 0:25 0:25.
The problem is that massive hepatic resection *creates* coagulopathy even in patients who start with normal clotting 0:52. The liver synthesizes clotting factors; removing a large portion of it acutely drops production 0:52. Diluting the remaining plasma with red cells alone worsens the imbalance 0:52. The study authors argue that this is exactly what happened: red cell transfusion without proportional plasma and platelet support drove the postoperative coagulopathy that required correction later 0:52.
The Argument for Balanced Transfusion
The authors recommend two changes 1:00 1:00. First, more careful patient selection for intraoperative transfusion — not every drop in hemoglobin requires immediate correction, and overtransfusing red cells may do harm 1:00. Second, when transfusion is necessary, use a balanced approach: red cells, plasma, and platelets in ratios that preserve coagulation rather than diluting it further 1:00.
This is not a new concept in trauma, where balanced transfusion protocols have become standard 1:00. The argument here is that hepatoblastoma resection should be treated similarly — not because the bleeding is traumatic in origin, but because the physiologic insult is comparable 1:00. You are removing a large portion of a highly vascular organ in a small patient with limited reserve 0:00. Maintaining oxygen-carrying capacity while ignoring coagulation is a strategy that may stabilize the intraoperative picture at the cost of a worse postoperative course 0:52.
What Remains Uncertain
This is an observational study, and the mortality association does not prove that transfusion caused death 0:32. Patients who received blood may have been sicker in ways the analysis could not fully capture — larger tumors, more difficult dissections, longer operative times 0:32. The study also does not provide transfusion thresholds or specific ratios for a balanced approach, so the recommendation is directional rather than prescriptive 1:00.
What is clear is that some patients received blood they likely did not need 0:39, and that red cell–predominant transfusion was followed by coagulopathy requiring additional component therapy 0:43. Whether a preemptive balanced strategy would improve outcomes is the next question, and it will require a prospective trial to answer definitively 1:00.
When to Involve Pediatric Surgical Oncology Early
For referring clinicians, the key point is that hepatoblastoma resection is not a straightforward hepatectomy 0:00. These cases require coordination between pediatric surgery, anesthesia, and transfusion medicine before the patient reaches the operating room 1:00. If imaging suggests a large or centrally located tumor, or if the child is small and the anticipated resection is substantial, early involvement of a center with experience in pediatric hepatobiliary surgery is appropriate 0:00 1:00. The decision about transfusion strategy — and whether to adopt a balanced protocol from the start — should be made before the first incision, not during active hemorrhage 1:00 1:00.
Takeaways from this story
- Intraoperative transfusion in hepatoblastoma resection was associated with increased mortality but not recurrence.
- Red cell–predominant transfusion may worsen postoperative coagulopathy rather than prevent it.
- Some patients received unnecessary transfusions, evidenced by elevated postoperative hemoglobin despite intraoperative blood.
- Authors recommend balanced transfusion (RBCs, plasma, platelets) rather than red cells alone during hepatoblastoma resection.
